arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Citius Pharmaceuticals, Inc.

CTXR Health Care Biotechnology: Pharmaceutical Preparations
$0.37
▼ -11.3% Today
as of Oct 22, 16:47 ET
Last 30 days -35.25% Sep 14 → Oct 22
$0.35 $0.42 $0.49 $0.55 $0.62 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.39
High
$0.39
Low
$0.37
Volume
$340,017
Avg Vol
$630,727
Mkt Cap
$16M
P/E (TTM)
—
Beta
—
52w High
$1.98
52w Low
$0.37
Div Yield
—
Shares Out
$27M

Recent Press Releases & News last 60 days · 2 items

Oct 12 · 12:30 PR PR Newswire
Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Sep 3 · 12:30 PR PR Newswire
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences

CTXR earnings at a glance

The options market is pricing a move of about ±839.0% after the report, a range of roughly -$2.73 to $3.47 from today's $0.37. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±11.0% on average; after the most recent report on May 15, 2026 it moved -2.8%. That means options currently expect more movement than CTXR has typically delivered. CTXR beat the consensus EPS estimate in 0 of its last 1 reported quarters. Implied volatility is currently 71%. The share price of $0.37 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.37
$1.98
0% of range
Avg surprise (last 1)
-17.6%
Avg reaction (last 2)
+8.2%
50% positive
Latest IV / EM
7102%
EM ±839.0% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.57$-1.19$-0.82$-0.44$-0.06 Actual $-0.07Actual $-0.06Actual $-1.45Actual $-1.34Actual $-1.57Actual $-1.30Actual $-1.27Est $-1.08Actual $-0.80Actual $-0.38Actual $-0.95Actual $-0.34 MarJunDecMarJunDecMar/2025Jun/2025DecMar/2026Jun
Revenue vs Net Income Revenue Net income
$-28M$-20M$-12M$-4M$4M Dec 24Mar 25Jun 25Dec 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.34 — — — — financials
Fri May 15, 2026Mar/2026 $-0.95 — — +25.2% -2.8% earnings
Wed Dec 31, 2025Dec 2025 $-0.38 — — — — financials
Tue Aug 12, 2025Jun/2025 $-0.80 — — — — earnings
Wed May 14, 2025Mar/2025 $-1.27 $-1.08 -17.6% — +19.2% earnings
Tue Dec 31, 2024Dec 2024 $-1.30 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.57 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.34 — — — — financials
Sun Dec 31, 2023Dec 2023 $-1.45 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.06 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.07 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1M$2M$4M—————
Cost of revenue$491,843$328,878$789,208—————
Gross profit$1M$1M$3M—————
Operating income$-12M$-32M$-9M—$-9M$-11M$-10M—
Net income$-12M$-28M$-9M—$-9M$-12M$-10M—
EPS (diluted)$-0.34$-0.95$-0.38—$-0.80$-1.27$-1.30—

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$17M$5M$8M$4M$6M$26,410$1M$3M
Inventory$23M$23M$23M$22M$17M$15M$14M$8M
Total current assets$43M$32M$38M$28M$25M$18M$18M$14M
Total assets$142M$133M$140M$131M$128M$121M$121M$117M
Long-term debt————————
Total liabilities$66M$63M$47M$53M$60M$58M$52M$43M
Total equity$67M$69M$93M$68M$68M$64M$69M$70M

Implied volatility — last 90 days

188%5019%9849%14679%19510% Jun 07 — IV 5028% · EM ±696.4%Jun 08 — IV 5269% · EM ±695.9%Jun 09 — IV 5600% · EM ±701.6%Jun 10 — IV 5971% · EM ±705.4%Jun 11 — IV 6243% · EM ±689.8%Jun 12 — IV 7060% · EM ±722.2%Jun 15 — IV 9856% · EM ±713.0%Jun 16 — IV 12502% · EM ±738.4%Jun 17 — IV 19510% · EM ±814.8%Jun 19 — IV 3230% · EM ±713.8%Jun 22 — IV 3280% · EM ±684.9%Jun 23 — IV 3448% · EM ±705.4%Jun 24 — IV 3504% · EM ±701.8%Jun 25 — IV 3887% · EM ±761.3%Jun 26 — IV 4064% · EM ±777.8%Jun 29 — IV 3804% · EM ±674.0%Jun 30 — IV 3872% · EM ±666.7%Jul 01 — IV 3834% · EM ±640.5%Jul 02 — IV 4142% · EM ±670.0%Jul 03 — IV 4288% · EM ±670.0%Jul 06 — IV 4635% · EM ±642.0%Jul 07 — IV 4996% · EM ±659.8%Jul 08 — IV 5585% · EM ±699.8%Jul 09 — IV 5882% · EM ±694.8%Jul 10 — IV 5980% · EM ±660.7%Jul 13 — IV 8536% · EM ±713.0%Jul 14 — IV 10394% · EM ±751.9%Jul 15 — IV 13136% · EM ±775.9%Jul 16 — IV 18762% · EM ±783.5%Jul 21 — IV 189% · EM ±43.9%Jul 23 — IV 209% · EM ±47.1%Jul 29 — IV 219% · EM ±43.9%Jul 30 — IV 250% · EM ±48.9%Jul 31 — IV 233% · EM ±44.6%Aug 03 — IV 189% · EM ±33.6%Aug 05 — IV 427% · EM ±71.3%Aug 07 — IV 422% · EM ±66.0%Aug 13 — IV 519% · EM ±61.3%Aug 24 — IV 3079% · EM ±643.0%Aug 25 — IV 3036% · EM ±621.2%Aug 26 — IV 2942% · EM ±589.2%Aug 27 — IV 2922% · EM ±572.3%Aug 28 — IV 3211% · EM ±614.5%Aug 31 — IV 3502% · EM ±620.5%Sep 01 — IV 4031% · EM ±694.1%Sep 02 — IV 3977% · EM ±664.4%Sep 03 — IV 3954% · EM ±639.5%Sep 04 — IV 4138% · EM ±646.6%Sep 07 — IV 4668% · EM ±646.6%Sep 08 — IV 4855% · EM ±641.1%Sep 09 — IV 5348% · EM ±670.1%Sep 10 — IV 5530% · EM ±653.3%Sep 11 — IV 6075% · EM ±671.3%Sep 14 — IV 8147% · EM ±680.5%Sep 15 — IV 9626% · EM ±696.3%Sep 16 — IV 11943% · EM ±705.4%Sep 17 — IV 15884% · EM ±663.4%Sep 21 — IV 3115% · EM ±650.5%Sep 22 — IV 3212% · EM ±657.2%Sep 23 — IV 3425% · EM ±685.9%Sep 24 — IV 3492% · EM ±684.0%Sep 25 — IV 3567% · EM ±682.7%Sep 28 — IV 4112% · EM ±728.6%Sep 29 — IV 4242% · EM ±730.4%Sep 30 — IV 4566% · EM ±762.7%Oct 01 — IV 4537% · EM ±733.9%Oct 02 — IV 4755% · EM ±743.0%Oct 06 — IV 6301% · EM ±832.1%Oct 07 — IV 6530% · EM ±818.2%Oct 08 — IV 7102% · EM ±839.0%

Sector peers

ALLR
Allarity Therapeutics, Inc.
$17M $0.85-3.4%
DARE
Dare Bioscience, Inc.
$17M $0.65-5.4%
RKTO
Rocket One Inc.
$17M $0.53+0.3%
LPCN
Lipocine Inc.
$18M $1.46-9.9%
KPTI
Karyopharm Therapeutics Inc.
$15M $0.55+52.1%
CYCN
Cyclerion Therapeutics, Inc.
$18M $3.36-85.7%

CTXR earnings FAQ

What is CTXR's expected move for earnings?

Options currently price a move of about ±839.0%, or $3.10 per share either way from $0.37.

How does CTXR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±11.0%, up 1 times and down 1 times.

What is CTXR's implied volatility?

CTXR's at-the-money implied volatility is about 71% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in